Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
¥15.00 - ¥64.00
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | ¥6.79B |
EV | ¥5.85B |
Shares Outstanding | 271.64M |
Beta | 0.37 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 22.50% |
EPS | 11.90% |
Operating Cash Flow | 11.40% |
Free Cash Flow | 8.50% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -213.42% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
OncoTherapy Science, Inc.
4564
Sector
Healthcare
Industry
Biotechnology
CEO
Shimada, Junichi
Employees
54
Website
www.oncotherapy.co.jpIPO Date
2005-09-29
Headquarters
1-2 Higashida-cho, Kawasaki-ku, Kawasaki, Kanagawa, 210-0005, Japan
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved